United States Diabetes Market Size Growth, Key Players & Latest Industry Trends Report 2034
Nitin Sharma· 7/5/2026
<p class="MsoNormal">IMARC Group has recently released a new research study titled &ldquo;<strong>United States Diabetes Market Size, Share, Trends and Forecast by Segment, 2026-2034</strong>&rdquo;, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.</p><p class="MsoNormal"><strong>United States Diabetes Market </strong><strong><span style="mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Calibri; color: black; mso-font-kerning: 0pt; mso-ligatures: none;">Size Overview</span></strong></p><p class="MsoNormal">The <a href="https://www.imarcgroup.com/us-diabetes-market">United States diabetes market size</a> was valued at&nbsp;USD 31.09 Billion&nbsp;in 2025 and is projected to reach&nbsp;USD 39.80 Billion&nbsp;by 2034, growing at a&nbsp;compound annual growth rate of 2.78%&nbsp;from 2026-2034.</p><p class="MsoNormal"><strong>Key Market Highlights</strong> for the <strong>United States Diabetes Market</strong></p><p class="MsoNormal"><span style="font-family: 'Segoe UI Emoji',sans-serif; mso-bidi-font-family: 'Segoe UI Emoji';">✔️</span> Growing awareness programs and early diagnosis initiatives supporting timely treatment adoption<br><span style="font-family: 'Segoe UI Emoji',sans-serif; mso-bidi-font-family: 'Segoe UI Emoji';">✔️</span> Rising demand for minimally invasive insulin delivery systems and smart insulin pens<br><span style="font-family: 'Segoe UI Emoji',sans-serif; mso-bidi-font-family: 'Segoe UI Emoji';">✔️</span> Increasing investment in research and development of novel antidiabetic drugs and combination therapies<br><span style="font-family: 'Segoe UI Emoji',sans-serif; mso-bidi-font-family: 'Segoe UI Emoji';">✔️</span> Strong uptake of wearable glucose monitoring devices integrated with mobile health applications<br><span style="font-family: 'Segoe UI Emoji',sans-serif; mso-bidi-font-family: 'Segoe UI Emoji';">✔️</span> Expansion of telehealth services improving chronic disease management accessibility<br><span style="font-family: 'Segoe UI Emoji',sans-serif; mso-bidi-font-family: 'Segoe UI Emoji';">✔️</span> Favorable reimbursement policies enhancing patient access to advanced diabetes care solutions<br><span style="font-family: 'Segoe UI Emoji',sans-serif; mso-bidi-font-family: 'Segoe UI Emoji';">✔️</span> Continuous innova
0